Elaine E. Weiner

I have 30 years of experience helping people with psychosis reach their recovery goals. Along with my experience managing clozapine, I am well versed in both pharmacological and non-pharmacological strategies to manage persistent positive and negative symptoms.  I have a long standing clinical and research interest in helping people with schizophrenia reduce and stop smoking cigarettes and have been a principle investigator in several smoking cessation protocols and written several manuscripts in this area. 

Recent Publications

Kelly DL, Hunt J, Vyas G, Glassman M, Brown CH, Wehring HJ, Love RC, Weiner E., Reeves G, Ehret MJ, Nucifora FC, Buchanan RW, Lanzkron S, Barr B, Richardson CM, Wonodi I, Kearns AM, Leistikow N, Liu F, Pugh S, Adams HA, Kreyenbuhl JA. A Randomized Controlled Trial of an Extension for Community Healthcare Outcomes (ECHO) Tele-mentoring Program to Increase Clozapine Utilization, Schizophrenia Bulletin, 2025; sbaf067. https://doi.org/10.1093/schbul/sbaf067. Co-Author.

Buchanan RW, Kelly DL, Strauss GP, Gold JM, Weiner E., Zaranski J, Shuo C, Blatt F, Holden J, Granholm E. Combined oxytocin and CBSST for social function in people with schizophrenia. Journal of Clinical Psychopharmacology 41(3):236-243, 2021. PMID: 33783399; DOI: 10.1097/JCP.0000000000001397. Co-Author.

Roche DJO, Bennett M, Weiner E. Pharmacological interventions to address cigarette smoking in people with schizophrenia spectrum disorders. Lancet Psychiatry 7(9):723-724, 2020. PMID: 32828151; DOI: 10.1016/S2215-0366(20)30353-9. Co-Author.